Dorsey & Whitney Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Sell |
2,493
-207
| -8% | -$92.1K | 0.06% | 259 |
|
|
2025
Q1 | $1.31M | Buy |
2,700
+146
| +6% | +$70.8K | 0.08% | 223 |
|
|
2024
Q4 | $1.03M | Buy |
2,554
+229
| +10% | +$92.2K | 0.06% | 260 |
|
|
2024
Q3 | $1.08M | Buy |
2,325
+40
| +2% | +$18.6K | 0.06% | 245 |
|
|
2024
Q2 | $1.07M | Sell |
2,285
-79
| -3% | -$37K | 0.07% | 214 |
|
|
2024
Q1 | $988K | Buy |
2,364
+35
| +2% | +$14.6K | 0.07% | 221 |
|
|
2023
Q4 | $948K | Sell |
2,329
-16
| -0.7% | -$6.51K | 0.07% | 218 |
|
|
2023
Q3 | $815K | Buy |
2,345
+12
| +0.5% | +$4.17K | 0.07% | 221 |
|
|
2023
Q2 | $821K | Buy |
2,333
+774
| +50% | +$272K | 0.07% | 233 |
|
|
2023
Q1 | $491K | Buy |
1,559
+527
| +51% | +$166K | 0.04% | 307 |
|
|
2022
Q4 | $298K | Sell |
1,032
-121
| -10% | -$34.9K | 0.03% | 411 |
|
|
2022
Q3 | $334K | Buy |
1,153
+227
| +25% | +$65.8K | 0.03% | 374 |
|
|
2022
Q2 | $262K | Sell |
926
-86
| -8% | -$24.3K | 0.03% | 438 |
|
|
2022
Q1 | $265K | Sell |
1,012
-193
| -16% | -$50.5K | 0.02% | 461 |
|
|
2021
Q4 | $264K | Buy |
+1,205
| New | +$264K | 0.02% | 446 |
|
|
2021
Q2 | – | Sell |
-1,097
| Closed | -$237K | – | 549 |
|
|
2021
Q1 | $237K | Buy |
1,097
+40
| +4% | +$8.64K | 0.02% | 458 |
|
|
2020
Q4 | $250K | Sell |
1,057
-139
| -12% | -$32.9K | 0.03% | 394 |
|
|
2020
Q3 | $326K | Buy |
1,196
+46
| +4% | +$12.5K | 0.04% | 284 |
|
|
2020
Q2 | $333K | Buy |
1,150
+211
| +22% | +$61.1K | 0.05% | 290 |
|
|
2020
Q1 | $224K | Buy |
+939
| New | +$224K | 0.04% | 333 |
|